SCHEMBL3718264

SCHEMBL3718264

CCC1CCCCN1c1cc(Cl)nc(N)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
LMNA P02545 1/20 0.46
KMT2A Q03164 2/20 0.41
MAP4K1 Q92918 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 2/20 0.39
NR1I2 O75469 2/20 0.37
SMARCA2 P51531 2/20 0.37
SMARCA4 P51532 2/20 0.37
PBRM1 Q86U86 2/20 0.37
NR1H2 P55055 1/20 0.37
NR1H3 Q13133 1/20 0.37
PDPK1 O15530 2/20 0.37
TGFBR1 P36897 1/20 0.37
AURKB Q96GD4 1/20 0.37
NPY5R Q15761 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1318813 0.96 MAPT (0.48) MAPTCYP1A2CYP2D6LMNAKMT2A
SCHEMBL3717623 0.82 PDPK1 (0.52) MAPTCYP1A2CYP2D6LMNAKMT2A
SCHEMBL605180 0.81 HRH4 (0.63) HRH4
SCHEMBL1319437 0.80 CYP1A2 (0.56) MAPTCYP1A2CYP2D6LMNAKMT2A
SCHEMBL3720514 0.79 MAPT (0.50) MAPTCYP1A2CYP2D6LMNAKMT2A
SCHEMBL83400 0.78 CUL4A (0.38) MAPTLMNAKMT2AMAP4K1KDM4E
SCHEMBL1320233 0.77 MAP4K1 (0.38) MAPTLMNAMAP4K1KDM4EHPGD
SCHEMBL3205548 0.77 MAPT (0.51) MAPTCYP1A2CYP2D6LMNAKMT2A
SCHEMBL5190994 0.76 NOS2 (0.56)
SCHEMBL1319079 0.74 MAPT (0.51) MAPTCYP1A2CYP2D6LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010120854-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-10-21 WO disclosed
WO-2010120854-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-10-21 WO disclosed